Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration-Reference-Cited by-同舟云学术

Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration

Published:2020-06-08 Issue:6 Volume:15 Page:e0234001
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shelestak John^ORCID,Singhal Naveen,Frankle Lana,Tomor Riely,Sternbach Sarah,McDonough Jennifer,Freeman Ernest,Clements Robert

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference74 articles.

1. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].;S. Komoly;Ideggyogyaszati Szle,2005

2. Division of giant mitochondria during recovery from cuprizone intoxication;B Tandler;J Cell Biol,1973

3. Animal models of Multiple Sclerosis;C Procaccini;Eur J Pharmacol,2015

4. Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction;M Faizi;Toxicol Mech Methods,2016

5. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis;ME Witte;Trends Mol Med,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypermobile Ehlers-Danlos syndrome and spontaneous CSF leaks: the connective tissue conundrum;Frontiers in Neurology;2024-07-17

2. CARS Imaging to Evaluate Neurodegenerative and Demyelinating Activity;Microscopy and Microanalysis;2024-07

3. AMP‐activated protein kinase as a mediator of mitochondrial dysfunction of multiple sclerosis in animal models: A systematic review;Journal of Cellular Physiology;2024-02-25

4. Interleukin-33 has the protective effect on oligodendrocytes against impairment induced by cuprizone intoxication;Neurochemistry International;2024-01

5. Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series;Journal of Personalized Medicine;2023-10-31